APAC Market Forecast
In the Asia Pacific allergy immunotherapy market is to generate the highest revenue by the end of 2037. Also, Asia Pacific is expected to hold a share of 36% during the forecast period. In countries, such as India and China, this is mainly due to the existence of a large proportion of the younger population that are more susceptible to sensitization. Moreover, a number of factors contributing to growth in this market in the Asia Pacific region are the presence of major key players in the market, investment from them, and uptake of medicines like Sublingual Immunotherapy with an overview of long-term results as well as dosage standardization.
North American Market Statistics
North America allergy immunotherapy market is expected to hold a significant share of 27% during the forecast period. The market expansion can be attributed to the region's high frequency of allergy diseases as well as the population's increased health consciousness. According to the World Allergy Organization, allergic rhinitis is the seventh most common chronic respiratory condition in the US, affecting 10–30% of the general adult population and approximately 405 children. A few other elements boosting the expansion in the area include high-end research and development, investments made by market participants, partnerships and acquisitions with significant industry participants, and strong emphasis on manufacturing facilities.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?